marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
Cara Therapeutics Financial Ratios 2011-2024 | CARA
Annual Financial Ratios Cara Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.5 | -6.2 | -7.0 | 85.3 | -6.4 | -7.4 | -8.1 | -6.8 | -9.0 | -12.7 | - | - | - |
P/S |
2.6 | 12.7 | 26.8 | 5.3 | 34.3 | 40.4 | 515.8 | 4497.9 | 58.3 | 71.2 | - | - | - |
EPS |
-2.2 | -1.6 | -1.7 | 0.2 | -2.5 | -2.1 | -1.9 | -2.1 | -1 | -0.8 | -0.7 | - | - |
EV (Enterprise Value) |
71.1 M | 493 M | 604 M | 685 M | 711 M | 586 M | 471 M | 388 M | 212 M | 178 M | -5.78 M | 1.98 M | 4.58 M |
EBITDA per Share |
-2.24 | -1.63 | -1.75 | 0.12 | -2.62 | -2.15 | -1.9 | -2.12 | -1.01 | -0.845 | - | - | - |
EV/EBITDA |
-6.7 | 155.1 | -6.0 | -6.8 | -7.8 | -6.5 | -8.3 | -9.8 | - | - | - | ||
PEG |
0.0 | 0.02 | 0.02 | 14.15 | 0.31 | 0.68 | -0.71 | 0.06 | 0.51 | 0.03 | - | - | - |
P/B |
0.9 | 3.4 | 2.5 | 2.6 | 3.7 | 4.1 | 5.4 | 7.6 | 2.1 | 4.4 | - | - | - |
P/CF |
-0.6 | -6.8 | -10.3 | -130.7 | -6.2 | -24.3 | -8.6 | -8.0 | -10.3 | -12.8 | - | - | - |
ROE % |
-207.61 | -53.83 | -38.87 | 3.38 | -56.97 | -55.39 | -66.98 | -112.92 | -23.50 | -34.35 | - | - | - |
ROA % |
-94.17 | -46.90 | -35.80 | 3.10 | -45.66 | -38.79 | -59.92 | -89.74 | -22.26 | -31.72 | - | - | - |
ROCE % |
-212.83 | -55.13 | -39.15 | 2.16 | -58.76 | -51.46 | -67.22 | -111.67 | -23.85 | -34.40 | - | - | - |
Current Ratio |
1.8 | 7.8 | - | - | 3.9 | 4.2 | 11.2 | 5.3 | 20.7 | 15.6 | - | - | - |
DSO |
52.4 | 14.2 | - | - | 32.8 | 43.1 | 342.2 | 3985.3 | 44.5 | 23.0 | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
52.4 | 14.2 | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
52.4 | 14.2 | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Cara Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.23 | -0.37 | -0.56 | - | -0.52 | -0.58 | -0.49 | - | -0.43 | -0.08 | -0.52 | - | -0.02 | -0.61 | -0.47 | 1.6 | -0.35 | -0.54 | -0.62 | -0.61 | -0.74 | -0.58 | -0.56 | -0.52 | -0.51 | -0.52 | -0.51 | -0.43 | -0.38 | -0.29 | -0.81 | -0.81 | -0.42 | -0.48 | -0.39 | -0.35 | -0.19 | -0.25 | -0.21 | -0.18 | -0.29 | -0.16 | -0.22 | -0.49 | -1.07 | 0.34 | -0.48 | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -0.54 | - | - | - | -0.51 | - | -0.44 | -0.08 | -0.52 | - | -0.02 | -0.61 | -0.47 | - | -0.36 | -0.55 | -0.64 | - | -0.77 | -0.6 | -0.58 | - | -0.53 | -0.53 | -0.52 | - | -0.39 | -0.29 | -0.81 | - | -0.38 | -0.44 | -0.38 | - | -0.17 | -0.23 | -0.2 | - | -0.26 | -0.15 | -0.21 | - | -0.69 | 1.71 | -0.36 | - | - | - | - | - | - | - | - |
ROE % |
-2072.95 | -341.04 | -197.36 | -81.15 | -93.69 | -73.50 | -46.66 | -28.19 | -28.68 | -16.63 | -29.68 | -25.71 | 5.98 | -0.16 | 4.88 | 3.38 | -43.64 | -54.60 | -56.83 | -56.97 | -57.10 | -54.03 | -54.60 | -55.39 | -56.27 | -56.09 | -53.94 | -66.98 | -93.96 | -102.37 | -117.43 | -112.92 | -78.68 | -60.48 | -40.12 | -23.50 | -22.51 | -30.62 | -32.26 | -34.35 | -22.40 | -1.27 | -4.09 | 7.33 | 3.46 | -5.00 | 4.87 | - | - | - | - | - | - | - | - |
ROA % |
-110.29 | -110.29 | -106.10 | -65.12 | -75.98 | -62.53 | -40.97 | -25.11 | -25.56 | -15.15 | -27.18 | -23.65 | 5.46 | -0.18 | 4.46 | 3.10 | -38.28 | -46.29 | -46.90 | -45.66 | -44.20 | -40.27 | -39.43 | -38.79 | -42.58 | -45.24 | -45.82 | -59.92 | -79.73 | -84.98 | -95.88 | -89.74 | -63.91 | -50.15 | -34.79 | -22.26 | -21.13 | -28.51 | -29.90 | -31.72 | -35.84 | -49.44 | -13.41 | -21.92 | -10.34 | 14.96 | -14.56 | - | - | - | - | - | - | - | - |
ROCE % |
-1129.46 | -316.24 | -196.71 | -83.67 | -96.57 | -75.73 | -48.23 | -28.76 | -29.31 | -16.95 | -29.93 | -25.94 | -32.78 | -39.07 | -34.29 | -29.28 | -47.72 | -59.33 | -61.86 | -43.76 | -59.08 | -55.95 | -56.35 | -41.46 | -56.39 | -56.00 | -53.77 | -51.76 | -74.97 | -83.25 | -98.42 | -71.14 | -75.91 | -57.47 | -36.65 | -14.72 | -27.50 | -35.51 | -37.24 | -26.59 | -20.04 | -0.71 | -6.32 | -3.45 | -3.45 | -10.00 | 2.79 | - | - | - | - | - | - | - | - |
Current Ratio |
1.0 | 1.2 | 1.5 | 1.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
14.2 | 95.6 | 95.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 521.4 | - | - | - | - | - | 19.5 | 22.8 | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
14.2 | 95.6 | 95.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 521.4 | - | - | - | - | - | 19.5 | 22.8 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
14.2 | 95.6 | 95.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 521.4 | - | - | - | - | - | 19.5 | 22.8 | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency